Hologic, Inc. (HOLX)

Market Cap	14.05B
Revenue (ttm)	4.03B
Net Income (ttm)	556.70M
Shares Out	222.85M
EPS (ttm)	2.39
PE Ratio	26.37
Forward PE	14.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,038,240
Open	62.05
Previous Close	62.01
Day's Range	61.52 - 64.15
52-Week Range	51.90 - 84.67
Beta	0.55
Analysts	Hold
Price Target	76.27 (+20.99%)
Earnings Date	Jul 28, 2025

About HOLX

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 21, 1990
• Employees: 6,990
• Stock Exchange: NASDAQ
• Ticker Symbol: HOLX
• Website: https://www.hologic.com

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Analyst Forecast

According to 13 analysts, the average rating for HOLX stock is "Hold." The 12-month stock price forecast is $76.27, which is an increase of 20.99% from the latest price.

Price Target

$76.27

(20.99% upside)

Analyst Consensus: Hold